Follow us on:
Breaking News
May 11, 2026
Breaking News
Breaking News
Allos _ENL_051126_650x90

Lilly to Invest an Additional $4.5B Across Two Indiana Sites

 
Lilly to Invest an Additional $4.5B Across Two Indiana Sites

Brings total Indiana capital expansion commitments since 2020 to more than $21 billion.
Read More >>

Headlines

Breaking News
Collaborations & Alliances

AGC Biologics Joins OTXL’s Clinical Development Network as a Manufacturing Partner

Will support a sustainable path from clinical development to commercial access for therapies serving the smallest patient populations.

SPONSOR

Late-Stage OSD Manufacturing for Commercial Success

Serán provides scalable OSD manufacturing with advanced process optimization, cGMP compliance, and regulatory expertise to ensure supply continuity and accelerated commercialization.

Breaking News

Charles River Laboratories Introduces AI-Powered, End-to-End Workflow

The new system is designed to significantly shorten nonclinical study timelines.

Breaking News
Promotions & Moves

CPTx Adds Edward Rebar as CSO, Promotes David Maier to CBO

Rebar will focus on translating CPTx’s proprietary ssDNA vector technology into in-vivo CAR-T therapeutic leads.

SPONSOR

Reduce risk and optimize consistent biomanufacturing growth

Choosing the right cell culture media supplier is critical to quality, consistency, and reliable supply. Learn five key factors to reduce risk and scale.

gChem_eBook_1225_650x250

Breaking News

VIVEbiotech Adds EvoLVcell to Its Catalogue of LVV-Manufacturing Products

EvoLVcell is designed to reduce batch‑to‑batch variability, improve vector quality, and provide a more predictable long‑term production strategy for LVVs.

SPONSOR

Five Decades of Partnership in Solid Oral Dose Manufacturing

How Ropack’s evolution from service provider to strategic CMO partner reflects broader shifts in manufacturing, packaging, and quality expectations.

Featured Resources

Solution Center SPOTLIGHT

PLD Pharma Services

PLD Pharma Services is a full-service CDMO providing end-to-end development and manufacturing for oral and solid dose Rx and OTC drugs across multiple delivery systems. With comprehensive R&D and analytical labs, an extensive formulation library, and a portfolio of more than 60 ANDAs, PLD supports products in solids, liquids, lozenges, and gummies. Backed by three decades of expertise, our integrated team advances programs from early concept through scale-up and commercial launch—all within a single, integrated team.

 

Solution Center SPOTLIGHT

Eurofins Central Laboratory

Eurofins Central Laboratory provides comprehensive safety, efficacy, biomarker, and pathology services through a global network of CAP-accredited laboratories, supporting clinical trials in more than 85 countries. Globally Harmonized, Personalized Partnership: We deliver the best of both worlds - you gain a trusted ally committed to your success.